ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "GLP-1 and Blindness"
Episode Synopsis
We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. … Continue reading "GLP-1 and Blindness"
More episodes of the podcast KGNU - How On Earth
Colorado’s Wildlife Action plan: Pt. I
30/12/2025
Coral: Past, Present, Future
22/12/2025
Wind: It’s Past & Future
16/12/2025
World Domination…by Slime Molds?
09/12/2025
Winter is Coming: Why Leaves Fall
11/11/2025
In God we trust